Casey's Misses Estimates; Potential Upside In Focus: Petrobras, Glaukos, Terns Pharma, Amazon, Netflix
- June 07th, 2023
- 1086 views
Casey's General Stores, Inc. (Nasdaq: CASY) announced its financial results for the fourth quarter of fiscal year 2023. The company reported earnings per share (EPS) of $1.49, which fell short of the consensus estimate of $1.59.
Following the earnings release, $CASY experienced a decline of 4.52%, trading at $214.13 in after-hours on Tuesday.
Petróleo Brasileiro S.A. - Petrobras (NYSE: PBR), a Brazilian multinational energy company, has been upgraded by Morgan Stanley from Equal-Weight to Overweight, with a raised price target of $16.5 compared to the previous target of $12.5.
Based on Tuesday's closing price of $12.65, this adjusted price target indicates a potential upside of approximately $3.85 or around 30.47% for $PBR, as per Morgan Stanley's assessment.
Glaukos Corporation (NYSE: GKOS), a medical technology and pharmaceutical company, has received an upgrade from Piper Sandler, shifting from Neutral to Overweight, along with a raised price target of $80, up from $55.
With $GKOS closing at $64.82 on Tuesday, this suggests a potential upside of about $15.18 or roughly 23.41% based on Piper Sandler's view.
Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a biopharmaceutical company focused on discovering and developing innovative therapies, has been initiated with a Buy rating by Jefferies, accompanied by a price target of $18.
With Tuesday's closing price of $11.63, this price target implies a potential upside of approximately $6.37 or around 54.76% for $TERN, according to Jefferies' analysis.
Amazon.com, Inc. (Nasdaq: AMZN), a global e-commerce and technology company, is being maintained with an Overweight rating by Piper Sandler, along with a raised price target of $150, up from $130.
With $AMZN closing at $126.61 on Tuesday, this suggests a potential upside of about $23.39 or roughly 18.48% based on Piper Sandler's outlook.
Netflix, Inc. (Nasdaq: NFLX), a leading entertainment streaming platform, is being maintained with an Overweight rating by JP Morgan, accompanied by a raised price target of $470, up from $380.
Based on Tuesday's closing price of $399.29, this implies a potential upside of approximately $70.71 or around 17.75% for $NFLX, according to JP Morgan's analysis.
It is important to note that the potential upside mentioned for each company is derived from the assessment of the respective brokerage firm, investment firm, or analysts. Investors are advised to perform their own research, evaluate additional factors, and exercise due diligence before making any investment decisions.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Herbal Works Celebrates Successful Earth Day Grand Opening and Extends Exclusive Grand Opening Offer
April 27th, 2026FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
April 24th, 2026April 23rd, 2026




Member Login